1. Home
  2. FTHY vs MRVI Comparison

FTHY vs MRVI Comparison

Compare FTHY & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust High Yield Opportunities 2027 Term Fund

FTHY

First Trust High Yield Opportunities 2027 Term Fund

HOLD

Current Price

$14.00

Market Cap

539.8M

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.62

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHY
MRVI
Founded
2020
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
539.8M
449.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FTHY
MRVI
Price
$14.00
$3.62
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.58
AVG Volume (30 Days)
176.7K
1.4M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
10.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$192,435,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.66
$1.67
52 Week High
$14.74
$6.21

Technical Indicators

Market Signals
Indicator
FTHY
MRVI
Relative Strength Index (RSI) 43.67 55.18
Support Level $14.01 $3.60
Resistance Level $14.17 $3.95
Average True Range (ATR) 0.11 0.19
MACD 0.00 -0.00
Stochastic Oscillator 41.43 50.39

Price Performance

Historical Comparison
FTHY
MRVI

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: